Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
Sydney, July 19, 2007 (ABN Newswire) - Solagran Limited (ASX: SLA) - Pharmaceutical Registration of Bioeffective R and Ropren - Mr Denis Kilroy, Executive Director; Solagran Limited (ASX: SLA) present the following audio webcast regarding "Pharmaceutical Registration of Bioeffective R and Ropren". You may also download this audio webcast to your computer or portable audio player.
ASX: SLA SOLAGRAN LIMITED Level 11 , 492 St Kilda Road MELBOURNE VIC 3004 (03) 9820 2699 Fax (03) 9820 3155 http://www.solagran.com General Manager: Mr Bob Anisimof General Manager: Dr Alex Jozsa Chief Op. Officer: Mr Geoff Webster Executive Director: Mr Denis Kilroy Executive Director: Mr Peter Stedwell Director: Mr Charles Pellegrino Chairman, Director: Dr Vagif Soultanov
This Audio Cast is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
Broadcaster: Solagran Limited (ASX: SLA)
Broadcast Title: Pharmaceutical Registration of Bioeffective R and Ropren
